<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Drug Discovery Online News</title>
    <description>News Articles</description>
    <link>http://www.drugdiscoveryonline.com/</link>
    <pubdate>11/30/2008 2:50:00 AM</pubdate>
    <item>
      <title>Orion Pharma Selects Chemdiv As A Partner In Drug Discovery Services </title>
      <description>ChemDiv, Inc. and Orion Pharma recently announced that Orion has chosen ChemDiv as a discovery partner in small molecule therapeutics for Orion's priority targets.
</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Orion-Pharma-Selects-Chemdiv-As-A-Partner-In-0002?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>11/30/2008 2:50:00 AM</pubdate>
    </item>
    <item>
      <title>FDA Approves Abbott's XIENCE V Drug Eluting Stent</title>
      <description>Abbott recentlty announced that the U.S. Food and Drug Administration (FDA) approved the XIENCE V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/FDA-Approves-Abbotts-XIENCE-V-Drug-Eluting-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>7/4/2008 4:33:00 AM</pubdate>
    </item>
    <item>
      <title>Joseph B. Bolen, Ph.D. From Millennium To Conference Chair Cancer Sessions At IBC's Drug Discovery &amp; Development Of Innovative Therapeutics Conference</title>
      <description>Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC Life Sciences Drug Discovery &amp; Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Boston &amp; Seaport Hotel in Boston, MA</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Joseph-B-Bolen-PhD-From-Millennium-To-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/30/2008 2:37:00 AM</pubdate>
    </item>
    <item>
      <title>Thermo Fisher Scientific's New TSQ Vantage LC-MS/MS Delivers Highest Sensitivity - Up To 10 Times More Than Existing Systems</title>
      <description>Thermo Fisher Scientific Inc. , the world leader in serving science, recently announced that it will launch the Thermo Scientific TSQ Vantage at ASMS 2008</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Thermo-Fisher-Scientifics-New-TSQ-Vantage-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/28/2008 1:57:00 AM</pubdate>
    </item>
    <item>
      <title>New Microplates For Ultra-High Throughput Drug Research.</title>
      <description>Porvair Sciences Ltd. has announced a new range of 1536-well microplates designed for drug research laboratories seeking to miniaturise both compound storage and management as well as cellular and biological assays</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/New-Microplates-For-Ultra-High-Throughput-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/25/2008 2:04:00 AM</pubdate>
    </item>
    <item>
      <title>St. Vincent de Paul Charitable Pharmacy Enrolls In AZ&amp;Me Prescription Savings Program For Healthcare Facilities </title>
      <description>AstraZeneca announced recently that it will provide free medication to St. Vincent de Paul Charitable Pharmacy in Cincinnati, under one of the company's prescription savings programs</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/St-Vincent-de-Paul-Charitable-Pharmacy-Enroll-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/24/2008 2:24:00 AM</pubdate>
    </item>
    <item>
      <title>Novel Process Interface And New Application For Insitec On-Line Particle Sizer At Arciblansa In Spain</title>
      <description>The success of a novel process interface developed by Malvern Instruments to provide Arciblansa (Alcora, Spain) with on-line particle size analysis has demonstrated the effectiveness of laser diffraction technology as an analytical tool for even the most demanding of wet process applications</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Novel-Process-Interface-And-New-Application-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/19/2008 3:33:00 AM</pubdate>
    </item>
    <item>
      <title>Versatile Freeze Dryers For Pilot, Research Or Small Scale Applications</title>
      <description>Genevac has announced the introduction of the VirTis Genesis Freeze Drying System offering unmatched versatility for pilot, research or small scale applications</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Freeze-Dryers-For-Pilot-Research-Small-Scale-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/13/2008 8:29:00 AM</pubdate>
    </item>
    <item>
      <title>Pharmacopeia And GlaxoSmithKline Collaboration Identifies A New Lead Compound</title>
      <description>Pharmacopeia  an innovator in the discovery and development of novel small molecule therapeutics, announced recently that it has identified a new lead compound for advancement in its alliance with GlaxoSmithKline , through its collaboration with the Center of Excellence for External Drug Discovery (CEEDD)</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Pharmacopeia-And-GlaxoSmithKline-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/4/2008 2:09:00 AM</pubdate>
    </item>
    <item>
      <title>Automating The Analysis Of Cell Viability</title>
      <description>Velocity11,an Agilent Technologies company, has released a new technical note that describes a combination of their Bravo liquid handler, BenchCel plate handling system and the CellTiter-Glo kit from Promega for automating the analysis of cell viability</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Automating-The-Analysis-Of-Cell-Viability-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/4/2008 1:22:00 AM</pubdate>
    </item>
    <item>
      <title>The New Tripos International Announces Release Of Benchware 3D Explorer Version 2.5 </title>
      <description>Tripos International, leading provider of drug discovery informatics products and services, today announced the release of Benchware 3D Explorer Version 2.5</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/The-New-Tripos-International-Announces-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/3/2008 2:27:00 AM</pubdate>
    </item>
    <item>
      <title>Simulations Plus Releases Software Update For Better Pharmaceutical Drug Design </title>
      <description>Simulations Plus, Inc. , a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released Version 4.5 of its ClassPharmer software for analysis of chemical libraries and design of new molecular structures</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Simulations-Plus-Releases-Software-Update-For-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/2/2008 3:30:00 AM</pubdate>
    </item>
    <item>
      <title>Applied Biosystems And BioTrove Team Up To Improve Drug Discovery With High-Throughput Mass Spectrometry Applications </title>
      <description>Applied Biosystems , an Applera Corporation business, recently announced that it has signed a non-exclusive reseller agreement with BioTrove, Inc. to offer an end-to-end mass spectrometry-based drug discovery workflow intended to help pharmaceutical companies make drug discovery more efficient</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Applied-Biosystems-And-BioTrove-Team-Up-To-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/2/2008 3:22:00 AM</pubdate>
    </item>
    <item>
      <title>MDS Pharma Services Adopts Innovative Technology For Bioanalysis</title>
      <description>MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, now offers its bioanalysis clients the benefits of electrochemiluminescent assay (ECLA) testing, with the recent installation and validation of two state-of-the-art instruments at its laboratory in Montreal</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/MDS-Pharma-Services-Adopts-Innovative-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>6/2/2008 3:13:00 AM</pubdate>
    </item>
    <item>
      <title>Thermo Fisher Scientific Introduces Exactive: A New Benchtop LC-MS System For Compound Screening And Identification</title>
      <description>Thermo Fisher Scientific Inc., the world leader in serving science, recently announced that it will launch the Thermo Scientific Exactive, a new benchtop LC-MS system designed for compound screening and identification applications, at ASMS 2008</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Thermo-Fisher-Scientific-Introduces-Exactive-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>5/29/2008 4:19:00 AM</pubdate>
    </item>
    <item>
      <title>Quark Pharmaceuticals Receives FDA Approval Of IND For Kidney Transplant siRNA Drug DGFi</title>
      <description>Quark Pharmaceuticals, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its siRNA drug candidate, DGFi, in kidney transplantation</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Quark-Pharmaceuticals-Receives-FDA-Approval-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>5/25/2008 4:41:00 AM</pubdate>
    </item>
    <item>
      <title>Systat Software Releases Sigmaplot 11&amp;reg; The Premier Graphing Application Now With Powerful Advisory Statistical Analysis Features</title>
      <description>Systat Software, Inc., a leading developer and supplier of award-winning scientific software products and services, released SigmaPlot 11, the most advanced scientific graphing and data analysis software available</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Systat-Software-Releases-Sigmaplot-11-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>5/20/2008 7:00:00 AM</pubdate>
    </item>
    <item>
      <title>MPL Announces New Miniature Pressure Switch, The MPL 5000X</title>
      <description>Micro Pneumatic Logic (MPL) is proud to announce a new cost effective miniature pressure switch targeting the OEM medical market.  </description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/MPL-Announces-New-Miniature-Pressure-Switch-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>5/20/2008 2:19:00 AM</pubdate>
    </item>
    <item>
      <title>Latest Cell Publication Describe The Novel Kinase Regulators Using OriGene's Functional Kinome Collection</title>
      <description>Scientists from University of Helsinki, Institute of Molecular Medicine in Finland and OriGene Technologies joined effort in creating the most comprehensive kinome collection of nearly all predicted human protein kinases, including the functional kinases and their kinase-deficient counterparts</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/OriGenes-Functional-Kinome-Collection-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>5/6/2008 10:36:00 AM</pubdate>
    </item>
    <item>
      <title>Syndexa Pharmaceuticals Corporation And ChemDiv, Inc. Announce Discovery Collaboration</title>
      <description>ChemDiv, Inc., a global CRO for drug discovery &amp; development, and Syndexa Pharmaceuticals Corporation, a biopharmaceutical company developing first-in-class drugs for the treatment of metabolic diseases, have announced recently the signing of a collaborative discovery research agreement</description>
      <link>http://www.drugdiscoveryonline.com/article.mvc/Syndexa-Pharmaceuticals-Corporation-And-Chem-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>4/28/2008 11:23:00 PM</pubdate>
    </item>
  </channel>
</rss>